» Articles » PMID: 34499652

Immunogenic Amino Acid Motifs and Linear Epitopes of COVID-19 MRNA Vaccines

Abstract

Reverse vaccinology is an evolving approach for improving vaccine effectiveness and minimizing adverse responses by limiting immunizations to critical epitopes. Towards this goal, we sought to identify immunogenic amino acid motifs and linear epitopes of the SARS-CoV-2 spike protein that elicit IgG in COVID-19 mRNA vaccine recipients. Paired pre/post vaccination samples from N = 20 healthy adults, and post-vaccine samples from an additional N = 13 individuals were used to immunoprecipitate IgG targets expressed by a bacterial display random peptide library, and preferentially recognized peptides were mapped to the spike primary sequence. The data identify several distinct amino acid motifs recognized by vaccine-induced IgG, a subset of those targeted by IgG from natural infection, which may mimic 3-dimensional conformation (mimotopes). Dominant linear epitopes were identified in the C-terminal domains of the S1 and S2 subunits (aa 558-569, 627-638, and 1148-1159) which have been previously associated with SARS-CoV-2 neutralization in vitro and demonstrate identity to bat coronavirus and SARS-CoV, but limited homology to non-pathogenic human coronavirus. The identified COVID-19 mRNA vaccine epitopes should be considered in the context of variants, immune escape and vaccine and therapy design moving forward.

Citing Articles

Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations.

Yalcin D, Bennett S, Sheehan J, Trauth A, Tso F, West J Int J Mol Sci. 2023; 24(8).

PMID: 37108460 PMC: 10138620. DOI: 10.3390/ijms24087292.


Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals.

Jaago M, Rahni A, Pupina N, Pihlak A, Sadam H, Tuvikene J Sci Rep. 2022; 12(1):16817.

PMID: 36207326 PMC: 9540097. DOI: 10.1038/s41598-022-20849-6.


Modular nanoarray vaccine for SARS-CoV-2.

Zagorski K, Pandey K, Rajaiah R, Olwenyi O, Bade A, Acharya A Nanomedicine. 2022; 46:102604.

PMID: 36113829 PMC: 9468299. DOI: 10.1016/j.nano.2022.102604.


Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System.

Yamaoka Y, Jeremiah S, Funabashi R, Miyakawa K, Morita T, Mihana Y Viruses. 2022; 14(7).

PMID: 35891441 PMC: 9321213. DOI: 10.3390/v14071461.


Depending on Epitope Profile of COVID-19 mRNA Vaccine Recipients: Are They More Efficient Against the Arising Viral Variants? An Opinion Article.

El-Baky N, Amara A Front Med (Lausanne). 2022; 9:903876.

PMID: 35795625 PMC: 9251123. DOI: 10.3389/fmed.2022.903876.


References
1.
Amrun S, Lee C, Lee B, Fong S, Young B, Chee R . Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity. EBioMedicine. 2020; 58:102911. PMC: 7375792. DOI: 10.1016/j.ebiom.2020.102911. View

2.
Garcia-Beltran W, Lam E, St Denis K, Nitido A, Garcia Z, Hauser B . Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021; 184(9):2372-2383.e9. PMC: 7953441. DOI: 10.1016/j.cell.2021.03.013. View

3.
Lu S, Xie X, Zhao L, Wang B, Zhu J, Yang T . The immunodominant and neutralization linear epitopes for SARS-CoV-2. Cell Rep. 2021; 34(4):108666. PMC: 7837128. DOI: 10.1016/j.celrep.2020.108666. View

4.
Abu-Raddad L, Chemaitelly H, Butt A . Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021; 385(2):187-189. PMC: 8117967. DOI: 10.1056/NEJMc2104974. View

5.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen T, Chromikova V, McMahon M . A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020; 26(7):1033-1036. PMC: 8183627. DOI: 10.1038/s41591-020-0913-5. View